このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Advanced Enzyme Technologies バランスシートの健全性
財務の健全性 基準チェック /66
Advanced Enzyme Technologiesの総株主資本は₹13.7B 、総負債は₹251.1Mで、負債比率は1.8%となります。総資産と総負債はそれぞれ₹15.4Bと₹1.6Bです。 Advanced Enzyme Technologiesの EBIT は₹1.7Bで、利息カバレッジ比率57.8です。現金および短期投資は₹5.5Bです。
主要情報
1.8%
負債資本比率
₹251.12m
負債
| インタレスト・カバレッジ・レシオ | 57.8x |
| 現金 | ₹5.46b |
| エクイティ | ₹13.71b |
| 負債合計 | ₹1.64b |
| 総資産 | ₹15.35b |
財務の健全性に関する最新情報
Recent updates
Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00
Jul 13
Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business
Apr 08Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Sep 23Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital
Feb 03Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends
Aug 11With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting
May 13Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture
Mar 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?
Mar 13Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)
Feb 21Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 18I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut
Feb 03
What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?
Jan 19What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?
Dec 28The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?
Dec 13Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Nov 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?
Nov 20Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today
Nov 05What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition
Oct 21Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?
Oct 06Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Stocks Shoot Up 31% But Its P/E Still Looks Reasonable
Sep 26Our Take On The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES)
Sep 21Does Advanced Enzyme Technologies (NSE:ADVENZYMES) Have A Healthy Balance Sheet?
Sep 08Have Insiders Sold Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Recently?
Aug 26Why We're Not Concerned About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Share Price
Aug 21Introducing Advanced Enzyme Technologies (NSE:ADVENZYMES), A Stock That Climbed 60% In The Last Year
Aug 20Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) P/E Is On The Mark
Aug 07財務状況分析
短期負債: ADVENZYMESの 短期資産 ( ₹8.1B ) が 短期負債 ( ₹1.1B ) を超えています。
長期負債: ADVENZYMESの短期資産 ( ₹8.1B ) が 長期負債 ( ₹580.3M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: ADVENZYMES総負債よりも多くの現金を保有しています。
負債の削減: ADVENZYMESの負債対資本比率は、過去 5 年間で4.9%から1.8%に減少しました。
債務返済能力: ADVENZYMESの負債は 営業キャッシュフロー によって 十分にカバー されています ( 563% )。
インタレストカバレッジ: ADVENZYMESの負債に対する 利息支払い は EBIT ( 57.8 x coverage) によって 十分にカバーされています。